Saltar al contenido principal
xMedica

NCT06942949ClinicalTrials.gov

Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Stones, A Pivotal Trial

En reclutamientoAdmite participantes ahora, según el registro.
Contactar con este estudio

En resumen

The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less…

De intervención101 participantes buscados20 centros1 país

Categorías

Registrado en 1 registro

Un mismo estudio puede estar registrado en varios registros. Lo mostramos una sola vez y enlazamos con todos los registros que tenemos.

La información del ensayo se muestra tal como la publicó el registro, en su idioma original.

¿Le interesa este estudio?

Iniciar sesión o cree una cuenta para registrar su interés y seguir este estudio.

How this study is set up

The points below are drawn from the public registry record for this study. Each one cites the field or sentence it came from. A dash (—) means the record does not state something — not that it is missing or wrong. Many well-run studies, especially small ones, leave some of these blank.

  • Present: Registered before enrolment beganFirst posted 2025-04-24; recorded start 2025-05-01
  • Present: Has a defined primary outcomeA primary outcome measure is listed in the record
  • Present: The primary outcome states a time frameThe primary outcome measure records a time frame
  • Not stated: Participants are not randomly assignedAllocation is recorded as non-randomised
  • Not stated: A comparison group is not stated in the registry recordThe record describes a single study arm
  • Not stated: Open label (no blinding)Masking is recorded as none (open label)
  • Not stated: An ethics committee is not stated in the registry recordThis registry's ingested record has no ethics-committee field
  • Not stated: Regulatory oversight (such as an IND or IDE) is not stated in the registry recordThis registry's ingested record has no regulatory-authorisation field
  • Not stated: A data monitoring committee is not stated in the registry recordThis registry's ingested record has no data-monitoring-committee fieldA data monitoring committee is not required for many smaller studies, and its absence here is not unusual.
  • Present: No cost to participants is mentioned in the recordChecked the summary, description and eligibility text; no cost-to-participant phrase found
  • Not stated: No other studies from this sponsor are in this databaseCounted from the lead sponsor named in the record (Avvio Medical)
  • Not stated: No posted results from this sponsor are in this database yetBased on the sponsor’s studies in this database
  • The record lists 1 condition.
  • Lead sponsor type recorded as: industry.

Trial stature

Three independent measures of this study, described from its registry record — not a recommendation about it. A rigorous study by investigators nobody has heard of is better evidence than a weak study led by a famous one. How these are scored.

Methodological rigourEXPLORATORY

An exploratory-stage design for a study of this type, judged from its ClinicalTrials.gov record.

How this score is built
  • Randomised allocation0/20

    Allocation not stated in the record

  • Blinding0/20

    Open-label

  • Control arm0/15

    No comparator arm stated in the record

  • Primary-outcome specificity10/10

    Named primary outcome with a defined time frame

  • Endpoint type3/10

    Surrogate or intermediate endpoint (conservative default)

  • Multi-centre8/8

    Multi-centre: 20 sites

  • Data monitoring committee0/7

    No data monitoring committee stated

  • Prospective registration5/5

    Registered before the study start date

  • Protocol / SAP posted0/5

    No protocol or SAP posted to the registry

ScaleSMALL

A small study: 101 participants (target), run at 20 sites.

How this score is built
  • Enrolment18/40

    101 participants (target)

  • Site count15/25

    20 sites

  • Country count0/15

    Single country

  • Planned duration6/10

    Planned over about 16 months

  • Sponsor scale0/10

    Avvio Medical has led 1 trials in our corpus

Investigator standingUNKNOWN

We have no verifiable track record for the investigator named on this trial. That is common for early-career investigators and for records held outside ClinicalTrials.gov — it is not a negative signal.

How this score is built
  • Investigator standing0/100

    No investigator recorded in the registry for this trial

These describe the registry record only, and today we hold ClinicalTrials.gov data. Absent fields lower a score, and absence often reflects registration practice rather than study quality. A high-stature trial is not necessarily safer or a better choice for you — enrolling in a large definitive trial can mean a higher chance of receiving placebo, while a small early-phase study may be the only route to a new therapy.

Resumen

The purpose of this study is to evaluate the safety and performance of the ELS to treat urinary stones. The ELS is intended to break urinary stones into small fragments that can pass during or after the procedure with less or no discomfort. Eligible patients are male or females, age 21 or older, with a single urinary stone in the ureter. Participants will undergo the ELS procedure and then be evaluated 30 days later for the presence or absence of urinary stone fragments on a CT scan. Subjects who still have stone present at Day 30 will be evaluated again at Day 60. Other outcome measures will be changes in pain, quality of life, and return to normal daily activities/work.

Afecciones

  • Kidney Calculi; Ureteral Calculi

Elegibilidad

Elegibilidad
SexoTodos
Edades21 YearsSin máximo
Voluntarios sanosNo

Elegibilidad tal como figura en el registro

Inclusion Criteria: * Male or Female aged \>=21 Years * Provides written informed consent * One urinary stone within the ureter, size \>=5 mm and \<=10 mm present on CT * Stone is indicated for Shock Wavve Lithotrips Per AUA 2026 guidelines * Stone to be treated has a maximum density of \<= 1200 HU Exclusion Criteria: * Anatomic presentations that would preclude obtaining an acoustic window for the ultrasound treatment * Non-calcium based stones (e.g., uric acid stones) * Untreated UTI * Presence of abnormal skin conditions in the area to be treated * Coagulation abnormality * Inability to lay still for 30 minutes * Pregnant * Abnormal Kidney Function * Any genitourinary history or procedure that has altered anatomy (e.g. urinary tract reconstruction)

Elegibilidad en frases sencillas

Los criterios de este registro aún no se han desglosado en frases separadas. El texto del registro anterior está completo y es la versión autorizada.

Diseño del estudio

Diseño del estudio
Tipo de estudioDe intervención
FaseNo aplicable
AsignaciónNo aplicable
Modelo de intervenciónSINGLE_GROUP
Propósito principalTREATMENT
EnmascaramientoNONE (0)
Inscripción101 participantes buscados

Patrocinador y colaboradores

  • Avvio Medical Patrocinador

Grupos e intervenciones

  • The ELS Trial is a prospective, multi-center, single arm study.EXPERIMENTAL

    All Subjects who qualify to participate in the ELS Trial will receive the experimental ELS procedure.

Intervenciones

  • Dispositivo ELS (Enhanced Lithotripsy System)

    ELS (Enhanced Lithotripsy System) utilizes low pressure ultrasound to actuate proprietary microbubbles administered into the urine to pit and fragment urinary stones.

Variables de resultado

  1. Variable de resultado principal

    Primary Outcome Measure

    CT assessment of the target stone demonstrating either (i) stone free status (zero fragments) or (ii) the presence of only stone fragments small enough to pass spontaneously (\<=4 mm) at 30 Days post procedure.

    Plazo From ELS treatment to 30 Days afterward.

Fechas

Fechas
Fecha de inicio1 de mayo de 2025 (real)
Finalización principal1 de agosto de 2026 (estimada)
Finalización1 de septiembre de 2026 (estimada)
Primera publicación24 de abril de 2025 (real)
Última actualización16 de junio de 2026
Resultados publicadosNo indicado en el registro
Estado verificado por última vezjulio de 2025

Real significa que el evento ocurrió. Estimada significa que el patrocinador lo prevé. Ambas cosas significan algo distinto.

Ubicaciones

12 centros están en reclutamiento

United States

United States
CentroCiudadEstado o regiónEstado
Michael G. Oefelein Clinical TrialsBakersfieldCaliforniaActivo, sin reclutar
University of VirginiaCharlottesvilleVirginiaRetirado
University of Virginia Community HealthCulpeperVirginiaActivo, sin reclutar
DukeDurhamNorth CarolinaActivo, sin reclutar
San Diego Clinical TrialsLa MesaCaliforniaEn reclutamiento
Comprehensive Urologic CareLake BarringtonIllinoisEn reclutamiento
Nebraska UrologyLincolnNebraskaNo indicado
Arkansas Urology Research CenterLittle RockArkansasNo indicado
University of Miami HospitalMiamiFloridaEn reclutamiento
Arizona State Urological Research InstitutePhoenixArizonaEn reclutamiento
Urology NevadaRenoNevadaNo indicado
University of Rochester Medical CenterRochesterNew YorkEn reclutamiento
Georgia UrologyRoswellGeorgiaEn reclutamiento
Golden State UrologySacramentoCaliforniaEn reclutamiento
Urology San AntonioSan AntonioTexasEn reclutamiento
Urology Specialists ClinicSioux CitySouth DakotaNo indicado
SUNY - Upstate Medical UniversitySyracuseNew YorkEn reclutamiento
Urology of VirginiaVirginia BeachVirginiaEn reclutamiento
Wichita Urology GroupWichitaKansasEn reclutamiento
Minnesota UrologyWoodburyMinnesotaEn reclutamiento

Documentos del estudio

No hay documentos enlazados en este registro.

Cambios a lo largo del tiempo

No se han registrado cambios desde que incorporamos este registro por primera vez.

Se registra un cambio cada vez que el patrocinador actualiza el registro. El estado, las fechas, la inscripción y los centros aparecen aquí a medida que cambian.